CDTX Cidara Therapeutics | $50.53
-0.7% | 6/23/2025 | Reiterated by | WBB Securities | Analyst Steve Brozak | Strong-Buy -> Strong-Buy | $45.00 | High | View details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 6/23/2025 |
MRKR Marker Therapeutics | $1.71
-5.0% | 4/1/2025 | Reiterated by | WBB Securities | Analyst Steve Brozak | Strong-Buy -> Strong-Buy | $12.50 -> $12.50 | High | View details for WBB Securities rating of Marker Therapeutics (NASDAQ:MRKR) on 4/1/2025 |
CDTX Cidara Therapeutics | $50.53
-0.7% | 12/5/2024 | Target Raised by | WBB Securities | - | Strong-Buy -> Strong-Buy | $40.00 -> $45.00 | N/A | View details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 12/5/2024 |
CDTX Cidara Therapeutics | $50.53
-0.7% | 4/25/2024 | Reiterated by | WBB Securities | - | Strong-Buy -> Strong-Buy | $40.00 | Low | View details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 4/25/2024 |
CDTX Cidara Therapeutics | $50.53
-0.7% | 9/22/2021 | Upgraded by | WBB Securities | - | Buy -> Strong-Buy | $125.00 | High | View details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 9/22/2021 |
OMER Omeros | $3.65
+5.5% | 6/18/2021 | Target Raised by | WBB Securities | - | Strong-Buy | $75.00 -> $100.00 | Medium | View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 6/18/2021 |
ARCT Arcturus Therapeutics | $13.78
-4.8% | 6/9/2020 | Downgraded by | WBB Securities | - | Buy -> Hold | $31.00 | Low | View details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 6/9/2020 |
CDTX Cidara Therapeutics | $50.53
-0.7% | 12/4/2019 | Upgraded by | WBB Securities | - | Speculative Buy -> Buy | $125.00 | Medium | View details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 12/4/2019 |
ADMA ADMA Biologics | $18.51
+0.2% | 4/4/2019 | Upgraded by | WBB Securities | - | Buy | | Low | View details for WBB Securities rating of ADMA Biologics (NASDAQ:ADMA) on 4/4/2019 |
MRKR Marker Therapeutics | $1.71
-5.0% | 3/29/2019 | Upgraded by | WBB Securities | - | Buy -> Strong-Buy | $7.29 | High | View details for WBB Securities rating of Marker Therapeutics (NASDAQ:MRKR) on 3/29/2019 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
ARCT Arcturus Therapeutics | $13.78
-4.8% | 9/20/2018 | Upgraded by | WBB Securities | - | Buy -> Strong-Buy | | Low | View details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 9/20/2018 |
SRPT Sarepta Therapeutics | $18.17
-4.7% | 6/20/2018 | Reiterated by | WBB Securities | - | Buy | | Low | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 6/20/2018 |
ARCT Arcturus Therapeutics | $13.78
-4.8% | 6/11/2018 | Upgraded by | WBB Securities | - | Hold -> Buy | | Medium | View details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 6/11/2018 |
CDTX Cidara Therapeutics | $50.53
-0.7% | 5/23/2018 | Upgraded by | WBB Securities | - | Hold -> Buy | | Medium | View details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 5/23/2018 |
OMER Omeros | $3.65
+5.5% | 3/26/2018 | Reiterated by | WBB Securities | - | Buy | $75.00 | High | View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 3/26/2018 |
CLDX Celldex Therapeutics | $22.91
+1.0% | 12/6/2017 | Reiterated by | WBB Securities | - | Buy | $150.00 | Low | View details for WBB Securities rating of Celldex Therapeutics (NASDAQ:CLDX) on 12/6/2017 |
ARCT Arcturus Therapeutics | $13.78
-4.8% | 10/9/2017 | Upgraded by | WBB Securities | - | Hold -> Buy | $2.00 | N/A | View details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 10/9/2017 |
LIVN LivaNova | $44.33
-5.0% | 8/15/2017 | Downgraded by | WBB Securities | - | Hold -> Sell | $50.00 | Low | View details for WBB Securities rating of LivaNova (NASDAQ:LIVN) on 8/15/2017 |
CDTX Cidara Therapeutics | $50.53
-0.7% | 8/11/2017 | Upgraded by | WBB Securities | - | Sell -> Hold | | Low | View details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 8/11/2017 |
OMER Omeros | $3.65
+5.5% | 6/14/2017 | Reiterated by | WBB Securities | - | Strong-Buy | $75.00 | High | View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 6/14/2017 |
OMER Omeros | $3.65
+5.5% | 3/30/2017 | Reiterated by | WBB Securities | - | Buy | $75.00 | Medium | View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 3/30/2017 |
CDTX Cidara Therapeutics | $50.53
-0.7% | 2/22/2017 | Upgraded by | WBB Securities | - | Sell -> Hold | $145.00 | N/A | View details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 2/22/2017 |
OMER Omeros | $3.65
+5.5% | 11/17/2016 | Reiterated by | WBB Securities | Analyst Stephen Brozak | Buy | $75.00 | N/A | View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 11/17/2016 |
ARCT Arcturus Therapeutics | $13.78
-4.8% | 11/2/2016 | Upgraded by | WBB Securities | - | Sell -> Hold | $4.00 -> $1.90 | N/A | View details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 11/2/2016 |
OMER Omeros | $3.65
+5.5% | 10/17/2016 | Reiterated by | WBB Securities | Analyst Stephen Brozak | Buy | $75.00 | N/A | View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 10/17/2016 |
SCYX SCYNEXIS | $0.70
+0.4% | 10/7/2016 | Upgraded by | WBB Securities | - | Buy -> Strong-Buy | $80.00 | N/A | View details for WBB Securities rating of SCYNEXIS (NASDAQ:SCYX) on 10/7/2016 |
CDTX Cidara Therapeutics | $50.53
-0.7% | 9/23/2016 | Downgraded by | WBB Securities | - | Hold -> Sell | $210.00 | N/A | View details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 9/23/2016 |
SRPT Sarepta Therapeutics | $18.17
-4.7% | 9/20/2016 | Reiterated by | WBB Securities | Analyst Stephen Brozak | Strong-Buy | $40.00 -> $60.00 | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 9/20/2016 |
ARCT Arcturus Therapeutics | $13.78
-4.8% | 9/12/2016 | Downgraded by | WBB Securities | - | Hold -> Sell | $5.00 -> $4.00 | N/A | View details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 9/12/2016 |
LIVN LivaNova | $44.33
-5.0% | 8/31/2016 | Reiterated by | WBB Securities | - | Hold | $60.00 | N/A | View details for WBB Securities rating of LivaNova (NASDAQ:LIVN) on 8/31/2016 |
SCYX SCYNEXIS | $0.70
+0.4% | 8/9/2016 | Upgraded by | WBB Securities | - | Speculative Buy -> Buy | $80.00 | N/A | View details for WBB Securities rating of SCYNEXIS (NASDAQ:SCYX) on 8/9/2016 |
OMER Omeros | $3.65
+5.5% | 6/14/2016 | Reiterated by | WBB Securities | - | Buy | $75.00 | N/A | View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 6/14/2016 |
SRPT Sarepta Therapeutics | $18.17
-4.7% | 6/8/2016 | Reiterated by | WBB Securities | Analyst Stephen Brozak | Buy | $40.00 | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 6/8/2016 |
SRPT Sarepta Therapeutics | $18.17
-4.7% | 5/2/2016 | Reiterated by | WBB Securities | Analyst Stephen Brozak | Strong-Buy | $40.00 | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 5/2/2016 |
SRPT Sarepta Therapeutics | $18.17
-4.7% | 4/26/2016 | Reiterated by | WBB Securities | Analyst Stephen Brozak | Buy | $40.00 | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 4/26/2016 |
SRPT Sarepta Therapeutics | $18.17
-4.7% | 3/30/2016 | Reiterated by | WBB Securities | Analyst Stephen Brozak | Buy | $40.00 | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 3/30/2016 |
TZOO Travelzoo | $12.89
-4.4% | 2/17/2016 | Initiated by | WBB Securities | - | Speculative Buy | $11.00 | N/A | View details for WBB Securities rating of Travelzoo (NASDAQ:TZOO) on 2/17/2016 |
SCYX SCYNEXIS | $0.70
+0.4% | 1/4/2016 | Initiated by | WBB Securities | Analyst Stephen Brozak | Buy | $80.00 | N/A | View details for WBB Securities rating of SCYNEXIS (NASDAQ:SCYX) on 1/4/2016 |
SCYX SCYNEXIS | $0.70
+0.4% | 12/29/2015 | Initiated by | WBB Securities | - | Buy | $80.00 | N/A | View details for WBB Securities rating of SCYNEXIS (NASDAQ:SCYX) on 12/29/2015 |
SRPT Sarepta Therapeutics | $18.17
-4.7% | 11/22/2015 | Reiterated by | WBB Securities | Analyst Stephen Brozak | Buy | $40.00 | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 11/22/2015 |
Google did what!?!? (Ad) A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.”
Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free. Gates and Altman are betting big—see why |
CTSO Cytosorbents | $1.06
-7.0% | 10/29/2015 | Upgraded by | WBB Securities | - | Speculative Buy -> Buy | $13.00 | N/A | View details for WBB Securities rating of Cytosorbents (NASDAQ:CTSO) on 10/29/2015 |
CDTX Cidara Therapeutics | $50.53
-0.7% | 10/9/2015 | Upgraded by | WBB Securities | - | Sell -> Hold | $260.00 | N/A | View details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 10/9/2015 |
OMER Omeros | $3.65
+5.5% | 8/18/2015 | Target Raised by | WBB Securities | - | Strong-Buy | $60.00 -> $75.00 | N/A | View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 8/18/2015 |
OMER Omeros | $3.65
+5.5% | 8/18/2015 | Reiterated by | WBB Securities | - | Buy | $60.00 | N/A | View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 8/18/2015 |
SRPT Sarepta Therapeutics | $18.17
-4.7% | 8/13/2015 | Reiterated by | WBB Securities | Analyst Stephen Brozak | Buy | $35.00 -> $40.00 | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 8/13/2015 |
ARCT Arcturus Therapeutics | $13.78
-4.8% | 8/9/2015 | Reiterated by | WBB Securities | - | Hold | $5.00 | N/A | View details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 8/9/2015 |
ARCT Arcturus Therapeutics | $13.78
-4.8% | 6/24/2015 | Downgraded by | WBB Securities | - | Speculative Buy -> Hold | $5.00 | N/A | View details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 6/24/2015 |
CLDX Celldex Therapeutics | $22.91
+1.0% | 6/1/2015 | Reiterated by | WBB Securities | Analyst Stephen Brozak | Buy | $450.00 -> $600.00 | N/A | View details for WBB Securities rating of Celldex Therapeutics (NASDAQ:CLDX) on 6/1/2015 |
SRPT Sarepta Therapeutics | $18.17
-4.7% | 5/22/2015 | Reiterated by | WBB Securities | Analyst Stephen Brozak | Strong-Buy | $25.00 -> $35.00 | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 5/22/2015 |
CDTX Cidara Therapeutics | $50.53
-0.7% | 4/23/2015 | Initiated by | WBB Securities | - | Sell | $260.00 | N/A | View details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 4/23/2015 |
CTSO Cytosorbents | $1.06
-7.0% | 2/25/2015 | Initiated by | WBB Securities | - | Speculative Buy | $13.00 | N/A | View details for WBB Securities rating of Cytosorbents (NASDAQ:CTSO) on 2/25/2015 |
SRPT Sarepta Therapeutics | $18.17
-4.7% | 1/15/2015 | Reiterated by | WBB Securities | Analyst Stephen Brozak | Buy | | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 1/15/2015 |
SRPT Sarepta Therapeutics | $18.17
-4.7% | 11/26/2014 | Upgraded by | WBB Securities | Analyst Stephen Brozak | Buy -> Strong-Buy | $25.00 | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 11/26/2014 |
SRPT Sarepta Therapeutics | $18.17
-4.7% | 7/29/2014 | Upgraded by | WBB Securities | Analyst Stephen Brozak | Speculative Buy -> Buy | | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 7/29/2014 |
SRPT Sarepta Therapeutics | $18.17
-4.7% | 7/29/2014 | Target Raised by | WBB Securities | Analyst Stephen Brozak | Speculative Buy -> Buy | $25.00 | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 7/29/2014 |
ARCT Arcturus Therapeutics | $13.78
-4.8% | 6/26/2014 | Initiated by | WBB Securities | - | Hold | $18.00 | N/A | View details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 6/26/2014 |
OMER Omeros | $3.65
+5.5% | 4/7/2014 | Target Raised by | WBB Securities | - | Strong-Buy | $20.00 -> $30.00 | N/A | View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 4/7/2014 |
SRPT Sarepta Therapeutics | $18.17
-4.7% | 11/26/2013 | Upgraded by | WBB Securities | - | Sell -> Speculative Buy | $9.00 -> $19.00 | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 11/26/2013 |
PATH UiPath | $12.36
-4.1% | 1/22/2013 | Upgraded by | WBB Securities | - | Buy -> Strong-Buy | $7.00 | N/A | View details for WBB Securities rating of UiPath (NYSE:PATH) on 1/22/2013 |
SSKN Strata Skin Sciences | $2.37
-1.3% | 9/24/2012 | Upgraded by | WBB Securities | - | Hold -> Speculative Buy | $200.00 -> $400.00 | N/A | View details for WBB Securities rating of Strata Skin Sciences (NASDAQ:SSKN) on 9/24/2012 |
SRPT Sarepta Therapeutics | $18.17
-4.7% | 9/12/2012 | Downgraded by | WBB Securities | - | Hold -> Sell | $8.00 -> $9.00 | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 9/12/2012 |
BCRX BioCryst Pharmaceuticals | $8.76
-1.4% | 8/14/2012 | Downgraded by | WBB Securities | - | Buy -> Hold | $8.50 -> $4.40 | N/A | View details for WBB Securities rating of BioCryst Pharmaceuticals (NASDAQ:BCRX) on 8/14/2012 |
SRPT Sarepta Therapeutics | $18.17
-4.7% | 8/9/2012 | Initiated by | WBB Securities | - | Buy -> Hold | $8.00 | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 8/9/2012 |
VCEL Vericel | $39.93
-3.2% | 7/24/2012 | Upgraded by | WBB Securities | - | Buy -> Strong-Buy | $3.00 -> $3.00 | N/A | View details for WBB Securities rating of Vericel (NASDAQ:VCEL) on 7/24/2012 |
VCEL Vericel | $39.93
-3.2% | 6/4/2012 | Upgraded by | WBB Securities | - | Speculative Buy -> Buy | $3.00 | N/A | View details for WBB Securities rating of Vericel (NASDAQ:VCEL) on 6/4/2012 |
VCEL Vericel | $39.93
-3.2% | 4/16/2012 | Upgraded by | WBB Securities | - | Hold -> Speculative Buy | $2.50 -> $3.00 | N/A | View details for WBB Securities rating of Vericel (NASDAQ:VCEL) on 4/16/2012 |
OMER Omeros | $3.65
+5.5% | 3/22/2012 | Target Raised by | WBB Securities | - | Strong-Buy | $10.50 -> $20.00 | N/A | View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 3/22/2012 |
JAZZ Jazz Pharmaceuticals | $110.27
-2.0% | 12/8/2011 | Downgraded by | WBB Securities | - | Buy -> Hold | $15.00 -> $40.00 | N/A | View details for WBB Securities rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 12/8/2011 |
VCEL Vericel | $39.93
-3.2% | 12/6/2011 | Upgraded by | WBB Securities | - | Sell -> Hold | $2.00 -> $2.50 | N/A | View details for WBB Securities rating of Vericel (NASDAQ:VCEL) on 12/6/2011 |
GERN Geron | $1.32
-4.3% | 11/16/2011 | Downgraded by | WBB Securities | - | Strong Buy -> Buy | $19.00 -> $6.00 | N/A | View details for WBB Securities rating of Geron (NASDAQ:GERN) on 11/16/2011 |
MBOT Microbot Medical | $2.62
-0.8% | 7/7/2011 | Initiated by | WBB Securities | - | Sell | $36.00 | N/A | View details for WBB Securities rating of Microbot Medical (NASDAQ:MBOT) on 7/7/2011 |
EBS Emergent Biosolutions | $7.34
+0.1% | 5/31/2011 | Target Raised by | WBB Securities | - | Strong Buy | $20.50 -> $30.00 | N/A | View details for WBB Securities rating of Emergent Biosolutions (NYSE:EBS) on 5/31/2011 |
PLX Protalix BioTherapeutics | $1.41
-4.7% | 3/17/2011 | Downgraded by | WBB Securities | - | Strong-Buy -> Buy | $100.00 | N/A | View details for WBB Securities rating of Protalix BioTherapeutics (NYSE:PLX) on 3/17/2011 |
VCEL Vericel | $39.93
-3.2% | 2/9/2011 | Initiated by | WBB Securities | - | Sell | $2.00 | N/A | View details for WBB Securities rating of Vericel (NASDAQ:VCEL) on 2/9/2011 |
OSIR Osiris Therapeutics | $18.99
| 1/31/2011 | Downgraded by | WBB Securities | - | Sell -> Sell Short | $5.00 -> $5.00 | N/A | View details for WBB Securities rating of Osiris Therapeutics (OTCMKTS:OSIR) on 1/31/2011 |
SRPT Sarepta Therapeutics | $18.17
-4.7% | 12/29/2010 | Initiated by | WBB Securities | - | Speculative Buy | $3.00 | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 12/29/2010 |
